Potential role of platelet-derived growth factor receptor inhibition using imatinib in combination with docetaxel in the treatment of recurrent non-small cell lung cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/21178640

Download in:

View as

General Info

PMID
21178640